WallStreetZenWallStreetZen

NASDAQ: OVID
Ovid Therapeutics Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

OVID past revenue growth

How has OVID's revenue growth performed historically?
Company
-73.93%
Industry
144.63%
Market
17.55%
OVID's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
OVID's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance

OVID earnings and revenue history

Current Revenue
$391.7k
Current Earnings
-$52.3M
Current Profit Margin
-13,362.2%

OVID Return on Equity

Current Company
-49.8%
Current Industry
-63.5%
Current Market
188%
OVID's Return on Equity (-49.8%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when OVID announces earnings.

OVID Return on Assets

Current Company
-38.2%
Current Industry
2.9%
OVID is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

OVID Return on Capital Employed

Current Company
-39.49%
Current Industry
19.5%
OVID has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

OVID vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
OVID$391.70k-$50.74M-$52.34M-98.95%N/A
RENB$0.00-$40.26M-$41.23MN/AN/A
TSVT$100.39M-$207.29M-$217.57M+12.96%N/A
QURE$15.84M-$253.10M-$308.48M+7.02%N/A
LCTX$8.95M-$22.60M-$21.49M+12.39%N/A
View Top Biotech Stocks

OVID earnings dates

Next earnings date
Jun 6, 2024

Ovid Therapeutics Earnings & Revenue FAQ

What were OVID's earnings last quarter?

On Invalid Date, Ovid Therapeutics (NASDAQ: OVID) reported Q4 2023 earnings per share (EPS) of -$0.22, up 37.5% year over year. Total Ovid Therapeutics earnings for the quarter were -$15.32 million. In the same quarter last year, Ovid Therapeutics's earnings per share (EPS) was -$0.16.

If you're new to stock investing, here's how to buy Ovid Therapeutics stock.

What was OVID's earnings growth in the past year?

As of Q2 2024, Ovid Therapeutics's earnings has grown year over year. Ovid Therapeutics's earnings in the past year totalled -$52.34 million.

What is OVID's earnings date?

Ovid Therapeutics's earnings date is Invalid Date. Add OVID to your watchlist to be reminded of OVID's next earnings announcement.

What was OVID's revenue last quarter?

On Invalid Date, Ovid Therapeutics (NASDAQ: OVID) reported Q4 2023 revenue of $141.56 thousand up 205.88% year over year. In the same quarter last year, Ovid Therapeutics's revenue was $46.28 thousand.

What was OVID's revenue growth in the past year?

As of Q2 2024, Ovid Therapeutics's revenue has grown -73.93% year over year. This is 218.56 percentage points lower than the US Biotechnology industry revenue growth rate of 144.63%. Ovid Therapeutics's revenue in the past year totalled $391.70 thousand.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.